Quantitative-Trait Loci on Chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 Control Variation in Levels of T and B Lymphocyte Subpopulations  by Hall, M.A. et al.
Am. J. Hum. Genet. 70:1172–1182, 2002
1172
Quantitative-Trait Loci on Chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18
Control Variation in Levels of T and B Lymphocyte Subpopulations
M. A. Hall,1 P. J. Norman,2 B. Thiel,3 H. Tiwari,3 A. Peiffer,4 R. W. Vaughan,2 S. Prescott,5
M. Leppert,4 N. J. Schork,6 and J. S. Lanchbury1
1Molecular Immunogenetics Unit, Department of Rheumatology, Division of Medicine, and 2Tissue Typing, Guy’s, King’s and St Thomas’
School of Medicine, Guy’s Hospital, London; 3 Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland;
4W. M. Keck Foundation/University of Utah Genetic Reference Project and 5Huntsman Cancer Institute, University of Utah, Salt Lake City;
and 6Department of Psychiatry, University of California at San Diego, La Jolla
Lymphocyte subpopulation levels are used for prognosis and monitoring of a variety of human diseases, especially
those with an infectious etiology. As a primary step to defining the major gene variation underlying these phenotypes,
we conducted the first whole-genome screen for quantitative variation in lymphocyte count, CD4 T cell, CD8 T
cell, B cell, and natural killer cell numbers, as well as CD4:CD8 ratio. The screen was performed in 15 of the
CEPH families that form the main human genome genetic project mapping resource. Quantitative-trait loci (QTLs)
that account for significant proportions of the phenotypic variance of lymphocyte subpopulations were detected
on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18. The most significant QTL found was for CD4 levels on chromosome
8 (empirical ). Two regions of chromosome 4 showed significant linkage to CD4:CD8 ratio (empiricalPp .00005
and ). A QTL for the highly correlated measures of CD4 and CD19 levels colocalized atPp .00007 Pp .003
18q21 (both ). Similarly, a shared region of chromosome 1 was linked to CD8 and CD19 levels (Pp .003 Pp
and , respectively). Several of the identified chromosome regions are likely to harbor polymorphic.0001 Pp .002
candidate genes responsible for these important human phenotypes. Their discovery has important implications
for understanding the generation of the immune repertoire and understanding immune-system homeostasis. More
generally, these data show the power of an integrated human gene–mapping approach for heritable molecular
phenotypes, using large pedigrees that have been extensively genotyped.
Introduction
A properly functioning immune system is a necessary
component of human survival. Cell populations that are
part of the immune system—and are responsible for
functional responses—carry surface structures that can
be recognized by monoclonal antibodies (Mabs). The
major lymphocyte populations identified in this way are
CD4 (CD4 antigen [MIM 186940]) and CD8 (CD8 an-
tigen [MIM 186910]) T cells, B cells (CD19 antigen
[MIM 107265]), and natural killer (NK) cells. These
subsets of lymphocytes play a vital role in defense against
tumors, bacteria, viruses, and other parasites, and in the
pathology of autoimmune diseases (Panayi et al. 1992;
Janeway and Travers 1996; Pardoll 2001). Levels of
these cells and derived measures such as CD4:CD8 ratio
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(CD4:CD8 T cell ratio [MIM 601083]) vary among hu-
mans, and a significant proportion of this variation ap-
pears to result from genetic differences (Amadori et al.
1995; Evans et al. 1999; Hall et al. 2000). The best
example of the clinical relevance of lymphocyte sub-
population variation is in the prognosis and monitoring
of the acquired immunodeficiency syndrome (AIDS). Pa-
tients with initially high levels of CD4 T cells and high
CD4:CD8 T cell ratios show slower progression to AIDS
than do patients with lower values (Hersh et al. 1984;
Taylor et al. 1989; Fahey et al. 1990; Coates et al. 1992;
Saah et al. 1992; Selwyn et al. 1992; Amadori et al.
1996).
As a first step in the identification of candidate genes
that specify variation in lymphocyte levels, we deter-
mined the degree of genetic control over quantitative
differences in six peripheral-blood lymphocyte subpop-
ulations by measuring the heritability of these pheno-
types. To identify quantitative-trait loci (QTLs) for the
six phenotypes, we performed linkage analysis with ge-
nome-scan data at ∼5-cM marker density in a cohort
of 15 healthy three-generation families that comprises
a maximum of 209 white individuals from Utah. This
is the first time that such a comprehensive set of im-
mune-system variables has been analyzed in this way,
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Table 1
Summary of Utah Genetic Reference Project (CEPH) Families Used for Linkage Analysis
TRAIT
NO. OF
Spouse Pairs Sibling Pairs Parent-Offspring Pairs
Lymphocyte count, CD4 T cell level, CD8 T cell level, CD4:CD8 ratio 18 385 225
CD19 B cell level 17 374 211
NK cell level 7 209 119
Table 2
Summary Statistics on Variables Measured in 15 Utah Genetic
Reference Project (CEPH) Families Used for Linkage Analysis
Variable No. Mean SD
Minimum
Value
Maximum
Value
Lymphocyte count 142 1.29 .45 .18 2.63
CD19 level 138 .16 .08 .02 .41
NK level 83 .06 .04 .001 .21
CD4 level 142 .59 .24 .08 1.4
CD8 level 142 .36 .16 .05 .94
CD4:CD8 ratio 142 1.81 .83 .19 6.25
Age 100 42.54 18.76 18 90
NOTE.—With the exception of CD4:CD8 ratio and age, values are
expressed in millions per milliliter.
and our findings should eventually lead to an improved
understanding of the genetic factors influencing the de-
velopment of the immune repertoire and of immune-
system homeostasis.
Subjects and Methods
Subjects
Subjects were recruited through the Utah Genetics
Reference Project (UGRP) based in Salt Lake City. In-
stitutional review board approval was obtained, and
each subject gave informed consent. These subjects are
a subset of the CEPH family collection, which is part of
the set of families from Utah that were originally col-
lected in the early 1980s. A brief description of these
families is given by White and colleagues (1985). The
aim was to obtain a set of samples representing large
sibships with grandparents. Complete three-generation
families were ascertained anecdotally. Originally, White
and colleagues sampled 18 families, each with four living
grandparents and seven or more children 15 years old,
as well as 10 families with similar characteristics. These
and other CEPH families have been used to generate
linkage maps as part of the CEPH Human Genome
Mapping Project (Dib et al. 1996).
The 15 families we phenotyped and analyzed in the
present study were CEPH pedigrees 1350, 1377, 1362,
1418, 1408, 1345, 1340, 1477, 1349, 1421, 1346,
1334, 1424, 1375, and 1358. Each family visited a clinic
at the University of Utah Medical Center, where phe-
notypic data were gathered and a thorough clinical ex-
amination was performed. Follow-up phenotyping was
not possible in every case, either because of deaths dur-
ing the intervening 17 years or because original siblings
were unavailable. The health status of the subjects was
evaluated through a full physical examination and in-
terview, and families were included for study without
any selection for segregation of disease.
Flow Cytometry
Fasting venous blood samples (5 ml) were drawn into
glass Vacutainer tubes containing sterile preservative-
free heparin (Becton Dickinson) and were used within
2 h. Samples were taken between 7:00 and 8:00 AM, to
minimize any circadian fluctuation in leukocyte popu-
lation levels.
Fluorescent-conjugated antibody mixtures were added
to 100 ml of whole blood, were incubated at 22C for
15 min, and were then processed using the ImmunoPrep
reagent system (Beckman Coulter), which includes a
1% paraformaldehyde fixation step. The cells then re-
main suitable for flow cytometry for as long as 5 d, when
kept at 4C. All Mabs used were directly conjugated
antihuman mouse IgG1 and were IgG1-FITC 679.1Mc7,
IgG1-PE 679.1Mc7, IgG1-Cy5 679.1Mc7, CD3-Cy5
UCHT1, and CD45-Cy5 J.33 (all Immunotech/Beckman
Coulter), as well as CD4-FITC SK3, CD8-PE SK1,
CD16FITC NKP15, CD19PE 4G7, and CD56PE MY31
(Becton Dickinson).
Flow cytometry was performed within 40 h of cell
fixation and was performed using a Coulter EPICS-XL
I set up for three-color detection and XL system II soft-
ware (Beckman Coulter). The cytometer was calibrated
daily, using ImmunoCheck beads (Beckman Coulter), to
maintain a half-peak coefficient of variation of !2 for
each channel. Lymphocytes were gated according to
their forward- and side-scatter properties, and 5,000
events were recorded. The lymphocyte purity of this re-
gion was calculated using a CD45-specific Mab and was
199% in each case. Positive thresholds were defined by
quadrant regions, which enclosed the negative control
population on each axis. FlowCount (Beckman Coulter)
beads were used to estimate the concentration of lym-
phocytes. Absolute lymphocyte numbers, in millions of
cells per milliliter of blood, were calculated using the
1174 Am. J. Hum. Genet. 70:1172–1182, 2002
Table 3
Variables Measured in 15 Utah Genetic Reference Project (CEPH) families Used for Linkage Analysis
VARIABLE
CORRELATION COEFFICIENTS (P) OF
CD19 NK CD4 CD8
CD4:CD8
Ratio Age
Lymphocyte count .69 (.0001) .45 (.0001) .87 (.0001) .80 (.0001) .02 (.80) .18 (.07)
CD19 .18 (.10) .57 (.0001) .44 (.0001) .07 (.40) .31 (.002)
NK .26 (.01) .57 (.0001) .24 (.02) .04 (.68)
CD4 .47 (.0001) .40 (.0001) .15 (.12)
CD8 .47 (.0001) .10 (.30)
CD4:CD8 ratio .08 (.43)
Table 4
Heritability Estimates (Determined
by Use of ASSOC) for Six
Immunological Phenotypes in 15
Utah Genetic Reference Project
(CEPH) Families
Trait Heritability
Lymphocyte count .611
CD19 B cell level .608
NK cell level .463
CD4 T cell level .564
CD8 T cell level .699
CD4:CD8 ratio .462
mean of quadruplicate samples. If one of the four sam-
ples could not be analyzed for technical reasons, the
mean was calculated from the remaining three samples.
When two of the samples could not be analyzed, the
data point was excluded from the study. Absolute num-
bers of lymphocyte subsets were determined as a per-
centage of the total number of lymphocytes.
STR Marker Genotyping
Genotype data for the 15 extended pedigrees used in
the present study were available from the CEPH data-
base. Genetic markers were largely autosomal STRs, and
positions were assigned using the Marshfield map (Bro-
man et al. 1998). The average intermarker distance was
∼5 cM. A detailed list of the 655 genetic markers used
is available from the authors.
Heritability Analysis
Table 1 summarizes the number of spouse-spouse, par-
ent-offspring, and sibling-sibling pairs available for anal-
ysis of immune phenotypes. Estimates of familial cor-
relations and their standard deviations were obtained
after traits were adjusted, according to the covariates
age and sex, using REGC. Heritability was calculated
from the familial correlations, using ASSOC2 within
SAGE (Statistical Analysis for Genetic Epidemiology),
under the assumption that parent-offspring and sibling-
sibling correlations are the same (SAGE 2001a).
QTL Analysis
QTL analysis was performed using the SIBPAL2 pro-
gram implemented in the SAGE package (SAGE 2001).
The W2 variation of the revised Haseman-Elston re-
gression approach was followed (Haseman and Elston
1972; Shete et al. 1999; Xu et al. 2000; SAGE 2001c).
The W2 method uses a weighted combination of squared
trait difference and squared mean–corrected trait sum
and is similar to the method described by Xu and col-
leagues (2000) and, with modifications, to the method
described by Shete and colleagues (1999). Weights are
chosen proportional to the inverse residual variance of
the squared differences and sums. The method for com-
bining pairs within multiple sibships is fully described
by Xu et al. (2000). In our data set, the W2 product
and difference variants of the revised Haseman-Elston
method gave comparable results (data not shown)
(Haseman and Elston 1972; Elston et al. 2000; Xu et
al. 2000). W2 results are reported. Age and sex were
included as covariates in the regression models. Neither
covariate was significant in most of the analyses.
Simulation of Empirical P Values
The method is described in the SAGE 4.0 manual
(SAGE 2001). Nominal P values were calculated assum-
ing the W2 test statistic follows a t distribution that is
asymptotically correct. However, because it was un-
clear whether the sample size was sufficient to ensure
asymptopia, we also calculated the P values empiri-
cally, using a Monte Carlo permutation method. We
permuted the allele sharing within families so that the
correlation structure among relatives remained the same.
The test statistics were then computed for each multi-
point marker position across the chromosome; 10,000
simulations were performed. The true test statistic was
then compared to the distribution of the permuted test
statistics (at each point) to derive the empirical P value
at each point.
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Table 5
Whole-Genome Scan of Quantitative Immune-System
Phenotypes
Chromosome
and Phenotype
Region
(cM) Empirical Pa Nominal Pb
1:
Lymphocyte count 200–231 .0013 .0018
CD19 197–228 .0024 .0039
CD4 227–252 .0015 .0057
CD8 196–222 .00013 .00020
2:
Lymphocyte count 28–54 .0026 .019
CD19 50–56 .0010 .0039
CD4 24–40 .00028 .00078
CD4:CD8 89 .0013 .006
3:
NK 192–199 .0048 .019
4:
CD4:CD8 2–5 .0027 .012
CD4:CD8 53–79 .00007 .00012
8:
Lymphocyte count 15–18 .0064 .014
CD19 16–20 .0029 .0040
CD4 65–79 .00005 .0039
9:
CD4 74–84 .00083 .0022
11
Lymphocyte count 38–39 .0052 .012
12:
CD19 149–156 .00082 .011
18:
CD19 93–100 .0033 .0054
CD4 99–105 .0028 .0051
NOTE.—Probabilities were calculated using the SIBPAL2 W2
method.
a Empirical significance levels (for ) by chromosomeP ! .01
regions, calculated using multipoint “new Haseman-Elston”
weighted regression method with both age and sex in the model
(Haseman and Elston 1972; Xu et al. 2000; SAGE 2001c).
b Nominal significance levels, with both age and sex in the model.
Quantitative Transmission/Disequilibrium Test (QTDT)
Analysis
The method proposed by George et al. (1999) was
used to conduct QTDT analysis. This test detects as-
sociation in the presence of linkage, does not require
independence of observations, and allows for analysis
of pedigree data and adjustment for covariates. The
maximum-likelihood estimates of the parameters and
the standard errors of the estimates are computed by
numerical methods. These procedures are implemented
in the program ASSOC2 of the SAGE software package
(SAGE 2001a).
Results
Distributions and Covariates
Table 2 shows distributions of values including num-
bers studied, means, standard deviations, and maximum
and minimum values for the six lymphocyte-subpopu-
lation parameters studied in the 15 CEPH pedigrees. All
values were within the ranges expected on the basis of
previously published data. Mean age of subjects was
42.5 years (SD 18.7 years; range 18–90 years). Variation
in several of the traits under study is highly correlated,
and Pearson correlation coefficients are summarized in
table 3. Relationships may be divided into trivial and
material. For example, the lymphocyte count variable is
largely additively composed of CD4 T cell, CD8 T cell,
CD19 B cell, and NK cell numbers. This leads to highly
significant correlations (each ). Other corre-Pp .0001
lations, however, such as CD19 B cells with both CD4
and CD8 T cells (0.57 and 0.44, both ) andPp .0001
NK cells with CD4 and CD8 T cells (0.26 and 0.57,
and , respectively) are not so easilyPp .01 Pp .0001
explained away and may reflect shared environmental
and/or genetic factors that impact upon multiple pheno-
types. Age was negatively correlated with CD19 B cell
level ( ) and nonsignificantly related to lym-Pp .002
phocyte count but had no significant effect on the other
phenotypes in these families.
Heritabilities
Estimates were obtained of familial correlations and
their standard deviations, when traits are adjusted by
the covariates age and sex (data not shown). These were
used to derive heritability estimates (table 4). All six of
the immune traits studied are under significant genetic
control, with CD8 T cell level being the most heritable
trait. These estimates are comparable to estimates de-
rived from twin studies of subjects in the same age range
(Hall et al. 2000).
Quantitative Linkage Analysis
Table 5 gives a summary of the most significant results
using the W2 method of a whole-genome scan for the
six quantitative immune phenotypes studied. Empirical
P values calculated by simulation ( ), togetherP ! .01
with nominal P values are shown for linkages adjusted
for the covariates age and sex. Nineteen covariate-ad-
justed phenotype-region combinations showed nominal
evidence of genetic linkage at this significance level.
QTLs accounting for significant proportions of the phe-
notypic variance of lymphocyte subpopulations were de-
tected on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18.
The most significant QTL found was for CD4 levels on
chromosome 8 at 65–79 cM (empirical ).Pp .00005
Two regions of chromosome 4 showed significant link-
age to CD4:CD8 ratio (fig. 1). The centromeric region
between 53 and 79 cM showed stronger linkage than
the telomeric region between 2 and 5 cM (empirical
and , respectively). A QTL for thePp .00007 Pp .003
highly correlated measure of CD4 and CD19 levels co-
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Figure 1 Chromosome 4 multipoint linkage map for six phenotypes under investigation. CD4:CD8 ratio was strongly linked, peaking
at 58 cM ( ). A less significant but coincident linkage was seen for CD8 and CD4:CD8 ratio in the p telomeric region ( ). QTLP ! .0001 P ! .01
analysis was performed with the W2 method in SIBPAL2, using all 15 families (excluding any grandparents who were available). Marker
distances were based on the Marshfield Clinic map. P values for linkage were derived empirically, using a Monte Carlo permutation method,
and are given as negative logs to base 10 on the abscissa.
localized at 18q21 (each empirical 3), as shownPp .00
in figure 2. This suggests the presence of a QTL that is
involved in determining CD4 T cell and B cell levels but
does not play a major role in CD8 T cell levels. Similarly,
a shared region of chromosome 1 (fig. 3) was linked to
CD8 and CD19 levels (empirical andPp .0001 Pp
, respectively) with considerable overlap with a re-.002
gion of linkage to lymphocyte count (empirical Pp
). This region is also adjacent to a region of linkage.001
to CD4 levels (empirical ). Further colocali-Pp .001
zation was apparent on chromosome 8, with a QTL in
an overlapping region showing significant linkage with
lymphocyte count and CD19 level (empirical Pp
and , respectively). As shown in figure 4,.006 Pp .003
CD4 level and lymphocyte count are linked to a shared
region of chromosome 2 (empirical andPp .0003
, respectively) that overlaps with a region ofPp .003
linkage to CD19 levels (empirical ). QTLs forPp .001
single lymphocyte subpopulations were found on chro-
mosomes 9 (CD4), 11 (lymphocyte count), and 12
(CD19) (see table 5).
Quantitative TDT Analysis
Linkage and association analyses are directed toward
identifying candidate genes whose variation accounts for
the variation in phenotype. The chromosome 18 region
linked to CD4 T cell and CD19 B cell levels contains a
number of candidate genes involved in lymphocyte sur-
vival and function that are worthy of investigation. One
prominent candidate gene in this region is Bcl-2, which
is involved in T- and B cell apoptosis and thus in control
of the size of these cellular populations. As a first step,
we genotyped an STR polymorphism associated with the
Bcl-2 gene in the CEPH families. This STR is located
543 bp upstream of the Bcl-2 start codon (Mehrian et
al. 1998). Six alleles were observed in the families.
QTDT analysis was performed for all six phenotypes
under investigation since they were highly correlated.
Significant transmission distortion was seen for allele 6,
with lymphocyte count and CD4 T cell level indicating
association in the presence of linkage (table 6) (Abecasis
et al. 2000; Martin et al. 2000). No significant results
were seen for the other four phenotypes tested.
Discussion
B and T cells are the major populations mediating the
adaptive arm of the immune system. In recent years,
there has been an explosion in the understanding of the
molecular basis of many components of the immune
system. Studies of animal models and individuals who
have naturally occurring deficiencies of the immune sys-
tem, along with improvements in molecular biology
techniques, have led to the identification of many of the
genes that are involved in the development and function
of the immune system (DiSanto et al. 1993; Puck 1994;
Leonard 1996; Elder 1998; Schuster and Kreth 2000).
These include genes responsible for lymphocyte subset
differentiation, cell function, immunity to various mi-
croorganisms, and lymphocyte activation or regulation.
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Figure 2 Chromosome 18 multipoint linkage map for six phenotypes under investigation. CD4 and CD19 achieved nominal P values of
.01 for at least one point on the chromosome. CD4, CD19, and lymphocyte counts are distinguished by an apparent region of coincident
linkage between 89 and 107 cM. QTL analysis was performed as described in the legend of figure 1.
Such studies reveal a complex set of developmental path-
ways that result in the generation of a large repertoire
of B and T lymphocytes, NK cells, monocytes, macro-
phages, and dendritic cells. Together, these provide the
individual with the capability of mounting successful
adaptive and innate immune responses. There are a num-
ber of genes characterized whose lack of function leads
to a total absence of a particular cell type and thus results
in a number of immune deficiencies in humans. In con-
trast, there is little knowledge of how genes may play a
role in modulating the actual levels of the individual cell
populations while still maintaining a functional balance
of the immune system.
The extent to which polymorphic genes account for
the variation in levels of functional populations of lym-
phocytes has until recently been an underinvestigated
area. Several studies have concentrated on T cell pop-
ulations, showing that variation in the important clin-
ical parameters of CD4 and CD8 T cell levels and CD4:
CD8 ratio are significantly heritable (Amadori et al.
1995; Evans et al. 1999; Hall et al. 2000). It has also
been suggested by segregation analysis that CD4:CD8
ratio and CD4 and CD8 T cell levels are under major
recessive gene control (Amadori et al. 1996; Clementi
et al. 1999). In the present study, we used extended
families to provide further heritability estimates of var-
iation among key immune cell populations of lympho-
cytes, CD4, CD8, CD19 B, and NK cells. We also used
a 5-cM genetic map to discover QTLs for variation in
these cell populations on a number of different chro-
mosomes. These data open the possibility of fine map-
ping and identifying positional candidates explaining
the observed variation. Nineteen chromosomal regions
showed significant levels of linkage over nine different
chromosomes. Five of the chromosomes showed linkage
to more than one phenotype and, in several instances,
a shared chromosomal region showed linkage to more
than one correlated phenotype. This suggests the pos-
sibility of one or several genes controlling variation in
the levels of several correlated lymphocyte subpopula-
tions. Gene-driven correlation between phenotypes may
exist, for at least two reasons. First, pleiotropic genes
may have direct effects on the variation across multi-
ple cell subpopulations through developmental or ho-
meostatic mechanisms. Second, the immune system is a
highly organized and mutually regulated complex.
Genes which affect one particular cell population may
exert an indirect effect upon a second dependent pop-
ulation. We recently showed that both of these classes
of gene control act to shape the covariation in CD4 and
CD8 T cell levels (Ahmadi et al. 2001). Examples of
shared regions are on chromosome 1 (CD19 and CD8),
chromosome 2 (lymphocyte count and CD4) and chro-
mosome 8 (lymphocyte count and CD19). In some in-
stances, these shared chromosomal regions overlap with
or are adjacent to a second region of linkage with an-
other correlated variable. Examples of this are the
shared region of chromosome 1, which is linked to
CD19 B cell and CD8 T cell levels and which overlaps
with a region showing linkage to CD4 T cells levels (see
table 5). Similarly, the region on chromosome 2 showing
linkage to CD4 T cell numbers and lymphocyte count
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Figure 3 Chromosome 1 multipoint map for six phenotypes under investigation. CD8, CD4, CD19, and lymphocyte counts achieved
nominal P values of .01 for at least one point on the chromosome. CD8, CD19, and lymphocyte counts are distinguished by an apparent
region of coincident linkage between 193 and 215 cM. QTL analysis was performed as described in the legend of figure 1.
Figure 4 Chromosome 2 multipoint map for six phenotypes under investigation. CD4, CD19, CD4:CD8 ratio, and lymphocyte count all
achieved nominal P values of .01 for at least one point on the chromosome. CD4 and lymphocyte count are distinguished by an apparent
region of coincident linkage around 32 cM. QTL analysis was performed as described in the legend of figure 1.
overlaps with a region showing linkage to CD19 B cells
numbers. There are also instances where more than one
region on the same chromosome shows significant link-
age to a phenotype, as is shown by two different regions
of chromosome 4 being linked to CD4:CD8 ratio.
Examination of the physical maps within these
regions of linkage suggests a number of positional can-
didate genes which merit further investigation. We ex-
amined the chromosome 18 region in some detail. It
encompasses the IDDM6, Bcl-2, and RANK loci all of
which have been implicated in T cell function and/or
autoimmune disease risk (Hawkins and Vaux 1997; An-
derson et al. 1997; Bain and Murre 1998; Merriman et
al. 2001). In particular, Bcl-2 is recognized as having a
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Table 6
Association of Bcl-2 STR Alleles with Lymphocyte Count
and CD4 T Cell Levels in UGRP/CEPH Families
Bcl-2 STR Alleles
Sample
Size Pa Corrected Pb
Lymphocyte count:
Allele 1 9 NS NS
Allele 2 15 NS NS
Allele 3 37 NS NS
Allele 4 0 … …
Allele 5 17 .03490 NS
Allele 6 7 !.000001 !.000006
CD4 T cell count:
Allele 1 9 NS NS
Allele 2 15 NS NS
Allele 3 37 NS NS
Allele 4 0 … …
Allele 5 17 NS NS
Allele 6 7 .00128 .00768
NOTE.—QTDT was assessed for Bcl-2 alleles against lym-
phocyte count and CD4 T cell levels, using the method of
George et al. (1999). Significant transmission distortion was
seen for allele 6, for lymphocyte count and CD4 T cell level,
indicating association in the presence of linkage. P values
are only calculated for transmitted alleles. NS p not
significant.
a Uncorrected significance level.
b Significance level with Bonferroni correction.
profound effect on lymphocyte survival and through
associated variation, could be a strong candidate for
determining heritable differences in lymphocyte subset
levels. To test this idea, we identified a polymorphic STR
within the first intron of the Bcl-2 gene and genotyped
it in the 15 families. Significant transmission distortion
was seen at this locus for allele 6 for the correlated
measures of lymphocyte count and CD4 T cell level,
indicating association in the presence of linkage. Further
work will be necessary to exhaustively identify variation
at this QTL and to examine its prediction of lymphocyte
and CD4 T cell levels in unrelated individuals. The ge-
netic evidence may also be viewed in light of the fact
that Bcl-2 has profound oncogenic potential (Butturini
and Gale 1990; Yang and Korsmeyer 1996) and that
mouse knockout studies show a key role of the gene in
T cell development from hematopoietic stem cells (Na-
kayama et al. 1994; Matsuzaki et al. 1997).
The results from the QTDT analysis show that, for
one phenotype (CD4 T cells), a proportion of the link-
age shown to chromosome 18 may be explained by
association to Bcl-2, whereas, for CD19 B cells, this
was shown not to be the case. Furthermore, there was
evidence of association of Bcl-2 allele 6 and lymphocyte
count, whereas there had originally not been any evi-
dence of linkage to this region in the data set studied.
This would suggest that relying on linkage results to
find candidate genes is not sufficient and is consistent
with the differences in sensitivity of the two approaches
(Risch 2000). Another obvious candidate region for var-
iable immune-system phenotypes is HLA. We found no
evidence for linkage between the parameters measured
and the HLA region at chromosome 6p21, although
this does not preclude effects that could be detected by
use of locus-specific markers and powerful association
tests.
Until now, studies of the impact of genetic variation
on the functioning of the immune system have largely
concentrated on qualitative issues of response and non-
response. Most studies have been conducted in the
mouse, and experimental manipulation of the murine
genome using knockout and transgenic technologies has
enabled insight to be gained in systems that are largely
driven to phenotypic extremes. Grupe et al. (2001) have
described potential improvements in the mapping of
QTLs for complex traits that enable rapid interval map-
ping between inbred mouse strains. Studies in humans
are less advanced. In the present study, we mapped a
number of QTLs for variation in multiple immune-sys-
tem parameters, using the core set of CEPH families
previously used for construction of the human genetic
map (Dib et al. 1996). The logic of this approach is
that a core set of human subjects organized into ex-
tended families can be used efficiently for mapping var-
iation that determines multiple human quantitative
traits. The approach is suitable for investigating heri-
table variables across the normal range, and it contrasts
with the popular strategy of linkage analysis of disease
traits in families with multiple affected individuals. We
foresee that our approach may establish a genetic win-
dow on the range of variation associated with “normal”
human physiology and function, with the eventual aim
of understanding the role of selection in shaping the
complex network of variation in biological traits. It is
unclear to what extent immune-system parameters, such
as CD4:CD8 ratio and T cell subset levels, are typical
complex traits. Heritabilities of ∼50% fall in the middle
of the range for human biological variables, and it is
encouraging that major QTLs appear to exist for some
of these parameters. Cytofluorographic measurements
are objective and very accurate. As a result, calculated
heritabilities will have a relatively low error rate, re-
flecting the low measurement error of the technique.
The accurate phenotype measure will increase the power
to map QTLs.
The degree to which the extremes of normal variation
may represent risk factors for common diseases remains
to be established more generally. Crude measures, such
as white cell count, were shown to be significantly in-
fluenced by genetic factors and to predict all-cause mor-
tality and specific mortality from coronary artery dis-
ease and cancer (Grimm et al. 1985; Whitfield and
Martin 1985; Hansen et al. 1990; Ensrud and Grimm
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1992). It is likely that heritable variation in immune-
system parameters has had adaptive value in the past.
This is most likely to have been the case in environments
where chronic and intense pathogen immune stimula-
tion was common, rather than in a contemporary West-
ern environment, such as the United States, from which
the families were sampled. However, rapid changes in
environmental conditions, such as the introduction of
new pathogens like HIV, may allow expression of the
adaptive value of the residual genetic and phenotypic
variation. The QTL which predicts CD4:CD8 ratio on
chromosome 4, for example, would have a profound
effect on the rate of progression of HIV disease in an
untreated subject (Fahey et al. 1990; Burcham et al.
1991). This and other QTLs that determine levels of
lymphocyte subsets may impact upon human health in
a variety of ways. However, the initial benefits of these
findings will be in furthering our understanding of the
development and homeostasis of the immune repertoire
in humans. We have applied conventional techniques to
the novel area of immune-system architecture. In a gen-
eral sense, the use of an integrated human gene-mapping
approach for heritable molecular phenotypes in large
pedigrees should be considered a powerful tool for un-
raveling the effects of polymorphic genes in human
health and disease.
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